The next medical device may hold a conversation with you. The FDA is preparing for what comes next
Generative artificial intelligence is pushing medical software beyond fixed predictions toward systems capable of conversation, synthesis and potentially autonomous actions. The FDA is now exploring whether these devices should be evaluated more like clinical professionals than conventional software.